by McKesson Ventures | Sep 27, 2021 | Portfolio News
There’s been a lot of talk about “femtech” booming over the past several months. However, a new report by Rock Health shows that even though there’s been a lot of funding in the space so far this year, it still accounts for a tiny fraction of total dollars going into...
by McKesson Ventures | Sep 21, 2021 | Portfolio News
FORTUNE and Great Place to Work have ranked Aledade as one of 2021’s Best Workplaces for Women. Ranked 12th on the list, it’s Aledade’s second year in a row receiving the honor. The annual FORTUNE and Great Place to Work awards are based on survey responses from...
by McKesson Ventures | Sep 17, 2021 | Portfolio News
The University of Oxford has opened a new study, which will trial a new multi-cancer early detection (MCED) blood test for early detection of more than 50 types of cancer. The study, SYMPLIFY, is also open at Oxford University Hospitals (OUH) and already includes more...
by McKesson Ventures | Aug 25, 2021 | Portfolio News
Our portfolio company, Hims & Hers, is in the process of distributing 10,000 free primary care and mental health visits to displaced Afghan refugees. According to a post on the company blog, Hims & Hers plans to coordinate with select non-governmental...
by McKesson Ventures | Aug 24, 2021 | Portfolio News
AllStripes recently closed a $50 million Series B funding round led by Lux Capital, with participation from McKesson Ventures, JAZZ Venture Partners, Spark Capital, Medidata Solutions (a Dassault Systèmes company), and Maveron, along with angel investors including...
by McKesson Ventures | Aug 18, 2021 | Portfolio News
As COVID-19 has caused a sea change in healthcare, with the rapid expansion of virtual healthcare and telemedicine, investors have been busy pouring their dollars into the digital health space. In fact, between January and June of 2021, almost $15 billion in funding...
